Annual Total Assets
$14.51 M
-$10.43 M-41.83%
31 December 2023
Summary:
Inhibikase Therapeutics annual total assets is currently $14.51 million, with the most recent change of -$10.43 million (-41.83%) on 31 December 2023. During the last 3 years, it has fallen by -$276.10 thousand (-1.87%). IKT annual total assets is now -65.84% below its all-time high of $42.47 million, reached on 31 December 2021.IKT Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$4.38 M
-$4.45 M-50.41%
30 September 2024
Summary:
Inhibikase Therapeutics quarterly total assets is currently $4.38 million, with the most recent change of -$4.45 million (-50.41%) on 30 September 2024. Over the past year, it has dropped by -$13.50 million (-75.52%). IKT quarterly total assets is now -91.11% below its all-time high of $49.22 million, reached on 30 June 2021.IKT Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.8% | -75.5% |
| 3 y3 years | -1.9% | -90.5% |
| 5 y5 years | +409.6% | - |
IKT Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.8% | at low | -90.5% | at low |
| 5 y | 5 years | -65.8% | >+9999.0% | -91.1% | >+9999.0% |
| alltime | all time | -65.8% | >+9999.0% | -91.1% | >+9999.0% |
Inhibikase Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.38 M(-50.4%) |
| June 2024 | - | $8.83 M(-20.3%) |
| Mar 2024 | - | $11.07 M(-23.7%) |
| Dec 2023 | $14.51 M(-41.8%) | $14.51 M(-18.9%) |
| Sept 2023 | - | $17.88 M(-20.0%) |
| June 2023 | - | $22.35 M(-20.7%) |
| Mar 2023 | - | $28.16 M(+12.9%) |
| Dec 2022 | $24.94 M | $24.94 M(-12.8%) |
| Sept 2022 | - | $28.58 M(-15.9%) |
| June 2022 | - | $33.99 M(-11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $38.39 M(-9.6%) |
| Dec 2021 | $42.47 M(+187.3%) | $42.47 M(-7.4%) |
| Sept 2021 | - | $45.87 M(-6.8%) |
| June 2021 | - | $49.22 M(+314.5%) |
| Mar 2021 | - | $11.87 M(-19.7%) |
| Dec 2020 | $14.78 M(>+9900.0%) | $14.78 M(+909.6%) |
| Sept 2020 | - | $1.46 M(+299.4%) |
| June 2020 | - | $366.60 K(+872.4%) |
| Mar 2020 | - | $37.70 K(-1.6%) |
| Dec 2019 | $38.30 K(-98.7%) | $38.30 K |
| Dec 2018 | $2.85 M | - |
FAQ
- What is Inhibikase Therapeutics annual total assets?
- What is the all time high annual total assets for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual total assets year-on-year change?
- What is Inhibikase Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly total assets year-on-year change?
What is Inhibikase Therapeutics annual total assets?
The current annual total assets of IKT is $14.51 M
What is the all time high annual total assets for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual total assets is $42.47 M
What is Inhibikase Therapeutics annual total assets year-on-year change?
Over the past year, IKT annual total assets has changed by -$10.43 M (-41.83%)
What is Inhibikase Therapeutics quarterly total assets?
The current quarterly total assets of IKT is $4.38 M
What is the all time high quarterly total assets for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly total assets is $49.22 M
What is Inhibikase Therapeutics quarterly total assets year-on-year change?
Over the past year, IKT quarterly total assets has changed by -$13.50 M (-75.52%)